Scientific standards and the design of case-control research

Thomas Imperiale, R. I. Horwitz

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A new controversy has emerged over the results of a case-control study alleging a causal relationship between certain non-steroidal anti-inflammatory agents (NSAIAs) and the risks of agranulocytosis and aplastic anemia. After describing the methods and results of the International Agranulocytosis and Aplastic Anemia (IAAA) study, we review the distinctive methodologic challenges of this study and the requirements for avoiding bias, and then reconcile the study results with the principles of case-control design. As a result of our analysis, we believe that the IAAA study's most important and reliable finding is its documentation of the infrequent occurrences of aplastic anemia and agranulocytosis with analgesic use. In contrast, a causal association between NSAIAs and blood dyscrasias has not been suitably established, and may well have resulted from several distinctive sources of bias. These include the effects of diagnostic-suspicion bias in case determination, of exclusion bias in choosing controls, of recall bias in determining exposure, and of publicity bias in both case selection and ascertainment of exposure. These problems could have been avoided and a more valid result obtained with closer attention to the experimental paradigm for case-control research.

Original languageEnglish (US)
Pages (from-to)187-196
Number of pages10
JournalBiomedicine and Pharmacotherapy
Volume43
Issue number3
DOIs
StatePublished - 1989
Externally publishedYes

Fingerprint

Agranulocytosis
Aplastic Anemia
Non-Steroidal Anti-Inflammatory Agents
Research
Documentation
Analgesics
Case-Control Studies

Keywords

  • scientific standards/case control research/NSAIAs/IAAA study

ASJC Scopus subject areas

  • Pharmacology

Cite this

Scientific standards and the design of case-control research. / Imperiale, Thomas; Horwitz, R. I.

In: Biomedicine and Pharmacotherapy, Vol. 43, No. 3, 1989, p. 187-196.

Research output: Contribution to journalArticle

@article{5ae6b8fafbe94b44af18349df8804891,
title = "Scientific standards and the design of case-control research",
abstract = "A new controversy has emerged over the results of a case-control study alleging a causal relationship between certain non-steroidal anti-inflammatory agents (NSAIAs) and the risks of agranulocytosis and aplastic anemia. After describing the methods and results of the International Agranulocytosis and Aplastic Anemia (IAAA) study, we review the distinctive methodologic challenges of this study and the requirements for avoiding bias, and then reconcile the study results with the principles of case-control design. As a result of our analysis, we believe that the IAAA study's most important and reliable finding is its documentation of the infrequent occurrences of aplastic anemia and agranulocytosis with analgesic use. In contrast, a causal association between NSAIAs and blood dyscrasias has not been suitably established, and may well have resulted from several distinctive sources of bias. These include the effects of diagnostic-suspicion bias in case determination, of exclusion bias in choosing controls, of recall bias in determining exposure, and of publicity bias in both case selection and ascertainment of exposure. These problems could have been avoided and a more valid result obtained with closer attention to the experimental paradigm for case-control research.",
keywords = "scientific standards/case control research/NSAIAs/IAAA study",
author = "Thomas Imperiale and Horwitz, {R. I.}",
year = "1989",
doi = "10.1016/0753-3322(89)90214-X",
language = "English (US)",
volume = "43",
pages = "187--196",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "3",

}

TY - JOUR

T1 - Scientific standards and the design of case-control research

AU - Imperiale, Thomas

AU - Horwitz, R. I.

PY - 1989

Y1 - 1989

N2 - A new controversy has emerged over the results of a case-control study alleging a causal relationship between certain non-steroidal anti-inflammatory agents (NSAIAs) and the risks of agranulocytosis and aplastic anemia. After describing the methods and results of the International Agranulocytosis and Aplastic Anemia (IAAA) study, we review the distinctive methodologic challenges of this study and the requirements for avoiding bias, and then reconcile the study results with the principles of case-control design. As a result of our analysis, we believe that the IAAA study's most important and reliable finding is its documentation of the infrequent occurrences of aplastic anemia and agranulocytosis with analgesic use. In contrast, a causal association between NSAIAs and blood dyscrasias has not been suitably established, and may well have resulted from several distinctive sources of bias. These include the effects of diagnostic-suspicion bias in case determination, of exclusion bias in choosing controls, of recall bias in determining exposure, and of publicity bias in both case selection and ascertainment of exposure. These problems could have been avoided and a more valid result obtained with closer attention to the experimental paradigm for case-control research.

AB - A new controversy has emerged over the results of a case-control study alleging a causal relationship between certain non-steroidal anti-inflammatory agents (NSAIAs) and the risks of agranulocytosis and aplastic anemia. After describing the methods and results of the International Agranulocytosis and Aplastic Anemia (IAAA) study, we review the distinctive methodologic challenges of this study and the requirements for avoiding bias, and then reconcile the study results with the principles of case-control design. As a result of our analysis, we believe that the IAAA study's most important and reliable finding is its documentation of the infrequent occurrences of aplastic anemia and agranulocytosis with analgesic use. In contrast, a causal association between NSAIAs and blood dyscrasias has not been suitably established, and may well have resulted from several distinctive sources of bias. These include the effects of diagnostic-suspicion bias in case determination, of exclusion bias in choosing controls, of recall bias in determining exposure, and of publicity bias in both case selection and ascertainment of exposure. These problems could have been avoided and a more valid result obtained with closer attention to the experimental paradigm for case-control research.

KW - scientific standards/case control research/NSAIAs/IAAA study

UR - http://www.scopus.com/inward/record.url?scp=0024405954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024405954&partnerID=8YFLogxK

U2 - 10.1016/0753-3322(89)90214-X

DO - 10.1016/0753-3322(89)90214-X

M3 - Article

VL - 43

SP - 187

EP - 196

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - 3

ER -